114 related articles for article (PubMed ID: 38356395)
21. [Down-regulation of histone deacetylase 2 induces cell apoptosis and inhibits cell proliferation and migration of laryngeal squamous cell carcinoma cells].
Yuan LL; Lou WH; Sang JZ; Li SL; Li WC
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):396-9. PubMed ID: 22932408
[TBL] [Abstract][Full Text] [Related]
22. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
23. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins.
Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park H; Lee JY; Nam SW
J Cell Biochem; 2012 Jun; 113(6):2167-77. PubMed ID: 22492270
[TBL] [Abstract][Full Text] [Related]
24. Histone deacetylase 3 inhibits expression of PUMA in gastric cancer cells.
Feng L; Pan M; Sun J; Lu H; Shen Q; Zhang S; Jiang T; Liu L; Jin W; Chen Y; Wang X; Jin H
J Mol Med (Berl); 2013 Jan; 91(1):49-58. PubMed ID: 22763818
[TBL] [Abstract][Full Text] [Related]
25. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
26. Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL.
Stubbs MC; Kim W; Bariteau M; Davis T; Vempati S; Minehart J; Witkin M; Qi J; Krivtsov AV; Bradner JE; Kung AL; Armstrong SA
Clin Cancer Res; 2015 May; 21(10):2348-58. PubMed ID: 25688158
[TBL] [Abstract][Full Text] [Related]
27. USP43 impairs cisplatin sensitivity in epithelial ovarian cancer through HDAC2-dependent regulation of Wnt/β-catenin signaling pathway.
Pei L; Zhao F; Zhang Y
Apoptosis; 2024 Feb; 29(1-2):210-228. PubMed ID: 38087046
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1.
Kong F; Wu K; Pang L; Huang Y; Li L; Xu J; Li F; Qing Y; Wang Z; Huang X; Xu S; Zhong X; Zhu Z; Wang X; Yang J
Oncol Res; 2022; 30(6):277-288. PubMed ID: 37303491
[TBL] [Abstract][Full Text] [Related]
29. HDAC2 selectively regulates FOXO3a-mediated gene transcription during oxidative stress-induced neuronal cell death.
Peng S; Zhao S; Yan F; Cheng J; Huang L; Chen H; Liu Q; Ji X; Yuan Z
J Neurosci; 2015 Jan; 35(3):1250-9. PubMed ID: 25609639
[TBL] [Abstract][Full Text] [Related]
30. HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.
Buurman R; Sandbothe M; Schlegelberger B; Skawran B
Eur J Med Res; 2016 Jun; 21(1):26. PubMed ID: 27342975
[TBL] [Abstract][Full Text] [Related]
31. Histone deacetylase HDAC2 silencing prevents endometriosis by activating the HNF4A/ARID1A axis.
Mai H; Liao Y; Luo S; Wei K; Yang F; Shi H
J Cell Mol Med; 2021 Nov; 25(21):9972-9982. PubMed ID: 34586697
[TBL] [Abstract][Full Text] [Related]
32. HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism.
Cui J; Xu F; Bai W; Zhao T; Hong J; Zuo W
J Transl Med; 2023 Feb; 21(1):125. PubMed ID: 36793108
[TBL] [Abstract][Full Text] [Related]
33. Ginsenoside Rg3 inhibits renal cell carcinoma cell migration, invasion, colony formation, and tube formation and enhances apoptosis through promoting the DNA demethylation and histone acetylation.
Ma Z; Zuo Y; Wang W
J Pharm Pharmacol; 2023 Jan; 75(1):76-86. PubMed ID: 36264186
[TBL] [Abstract][Full Text] [Related]
34. HDAC2 overexpression is a poor prognostic factor of breast cancer patients with increased multidrug resistance-associated protein expression who received anthracyclines therapy.
Zhao H; Yu Z; Zhao L; He M; Ren J; Wu H; Chen Q; Yao W; Wei M
Jpn J Clin Oncol; 2016 Oct; 46(10):893-902. PubMed ID: 27432453
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of tescalcin by modification of promoter methylation controls cell survival in gastric cancer cells.
Kim TW; Han SR; Kim JT; Yoo SM; Lee MS; Lee SH; Kang YH; Lee HG
Oncol Rep; 2019 Jun; 41(6):3464-3474. PubMed ID: 31002343
[TBL] [Abstract][Full Text] [Related]
36. HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.
Hu XT; Xing W; Zhao RS; Tan Y; Wu XF; Ao LQ; Li Z; Yao MW; Yuan M; Guo W; Li SZ; Yu J; Ao X; Xu X
J Exp Clin Cancer Res; 2020 Dec; 39(1):270. PubMed ID: 33267897
[TBL] [Abstract][Full Text] [Related]
37. Effect and mechanism of microRNA-515-5p in proliferation and apoptosis of trophoblast cells in preeclampsia via manipulating histone deacetylase 2.
Zhang K; Zhang H; Gao S; Sun C; Wang B
Mol Reprod Dev; 2023 Jan; 90(1):59-66. PubMed ID: 36580437
[TBL] [Abstract][Full Text] [Related]
38. Weighted gene co-expression network analysis and connectivity map identifies lovastatin as a treatment option of gastric cancer by inhibiting HDAC2.
Zhang L; Kang W; Lu X; Ma S; Dong L; Zou B
Gene; 2019 Jan; 681():15-25. PubMed ID: 30266498
[TBL] [Abstract][Full Text] [Related]
39. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
Fan H; Zhang YS
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylase 2 modulates p53 transcriptional activities through regulation of p53-DNA binding activity.
Harms KL; Chen X
Cancer Res; 2007 Apr; 67(7):3145-52. PubMed ID: 17409421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
